Financials
- Market Capitalization 1.26 B
- Employee 592
- Founded N/A
- CEO Michael Castagna
- Website www.mannkindcorp.com
- Headquarter Delaware, United States
- FIGI BBG000PPL3G9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-32.77
市销率
3.45
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2302 | MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 14.77 USD | -1.47% | -3.72% | -20.16% | +54.50% | 1.26 B USD | ||
| 2306 | IMTX Immatics N.V. - Ordinary Shares | 9.40 USD | -0.53% | +8.17% | +9.05% | -9.18% | 1.26 B USD | ||
| 2359 | CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 13.96 USD | -1.41% | -0.92% | +6.00% | +145.34% | 1.17 B USD | ||
| 2370 | GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 13.58 USD | +1.49% | +0.82% | -18.39% | +20.18% | 1.16 B USD |